• Home
  • News
  • Videos
  • Podcasts
  • Slides
  • Visual Abstracts
  • Topics
    • Acute Coronary Syndrome
    • Arrhythmia and Electrophysiology
    • Cardiovascular Imaging
    • Cardiovascular Intervention
    • Cardiovascular Prevention
    • Cerebrovascular Disease
    • Heart Failure
    • Peripheral Vascular Disease
    • Structural Heart Disease
    • Valvular Heart Disease
  • Conferences
    • SCAI 2018
    • ACC 2018
    • AHA 2017
    • ESC 2017
    • SCAI 2017
    • ACC 2017
Log In

ODYSSEY Outcomes: Alirocumab Reduces CV Outcomes and All-Cause Mortality in ACS Patients

Dr. Schwartz and Dr. Gibson Discuss

Subscribe on iTunes or Google Play.

http://cardiologynownews.org/wp-content/uploads/2018/03/sun_945_schwartz.mp3

Podcast: Download

t f

More from ACC 2018

Low Dose Rivaroxaban Plus Aspirin Reduces Major Adverse Limb Events in COMPASS

According to a new subgroup analysis of the COMPASS trial published in the Journal of… Continue Reading

Sudarshana Datta, M.D.
By Sudarshana Datta, M.D.
May 29, 2018

SWAP 4 trial: De-escalation of P2Y12 Inhibitors

In a recent article published in The Circulation, it has been found that the use… Continue Reading

Aditya Ganti, M.D.
By Aditya Ganti, M.D.
March 23, 2018

HeartMate 3: Magnetic Pump in Advanced Heart Failure

According to a new study published in the New England Journal of Medicine, a fully… Continue Reading

Sudarshana Datta, M.D.
By Sudarshana Datta, M.D.
March 21, 2018
Create an Account
Register for Cardiology Now News
CLICK TO REGISTER
Cardiology Now News is sponsored by the Baim Institute for Clinical Research and produced by the PERFUSE Study Group. Baim and PERFUSE are academic research organizations led by world class cardiovascular clinical trialists and opinion leaders.
Sign Up for Our Newsletter
Receive the latest news, interviews, podcasts directly to your inbox
About Cardiology Now | Editorial Board | Advertising | Terms of Use | Privacy Policy | Contact Us
© 2018 Baim Institute for Clinical Research, Inc. All rights reserved. Unauthorized use prohibited. The Baim Institute for Clinical Research is a qualified 501(c)(3) tax-exempt organization. This website is certified by Health On the Net Foundation. Click to verify.